Age-Related Differences in the Reproductive and Metabolic Implications of Polycystic Ovarian Syndrome: Findings in an Obese, United States Population

    April 2012 in “ Gynecological Endocrinology
    Erica Johnstone, George M. Davis, Lee T. Zane, Marcelle I. Cedars, Heather G. Huddleston
    Image of study
    TLDR Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.
    The study, which included 229 obese women from the United States with polycystic ovarian syndrome (PCOS), found age-related differences in the condition's manifestations. Women were divided into three age groups: 18-25 (71 participants), 26-35 (129 participants), and 36-45 (29 participants). Results showed that older women (36-45) had a lower prevalence of biochemical hyperandrogenemia but worse metabolic profiles, with a fourfold increase in the odds of metabolic syndrome compared to younger women. They also had larger waist circumferences and higher levels of diastolic blood pressure, total cholesterol, and fasting glucose. The study suggests that cardiovascular risks in women with PCOS may increase with age, despite a decrease in androgen levels, and that insulin resistance may be independent of hyperandrogenemia. The findings are limited to an obese, urban US population and may not apply to lean women with PCOS. The research indicates that current diagnostic criteria might not adequately detect PCOS in older women, who may have an elevated health risk.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 19 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community PCOS Hair Loss: What’s Helped Me (and What Didn’t)

      in Treatment  11 upvotes 2 weeks ago
      OP shares their experience with PCOS-related hair loss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.

      community I think this is my stop, gentlepeople. So long and thanks for all the data 👋

      in Transgender  2243 upvotes 2 months ago
      A user shared their successful experience with hair regrowth and transitioning from male to female using minoxidil, finasteride, Nutrafol, microneedling, and hormone replacement therapy (HRT). They expressed gratitude for the results and encouraged others to explore treatments that align with their personal goals.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 1 year ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

    Similar Research

    5 / 1000+ results